Schonfeld Strategic Advisors LLC A Ikido Pharma Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 17,700 shares of AIKI stock, worth $67,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,700Holding current value
$67,260% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AIKI
# of Institutions
25Shares Held
958KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA320KShares$1.22 Million0.0% of portfolio
-
Connective Capital Management, LLC Palo Alto, CA266KShares$1.01 Million1.35% of portfolio
-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.3KShares$251,8750.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny52.3KShares$198,6030.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...